HHS supports FDA’s proposed e-cigarette crackdown, HHS Chief Azar says

Health, Fitness & Food

Regulators aren’t going to allow what they’re calling an epidemic of e-cigarette use among teens become a “pathway to nicotine dependency,” Health and Human Services Secretary Alex Azar told CNBC on Friday.

The e-cigarette craze has driven what’s arguably the largest uptick of teen nicotine use in decades after years of driving cigarette smoking rates to record lows. Teens who would have never smoked cigarettes are happily inhaling fruity flavors, sometimes without realizing it is packed with nicotine, an addictive substance.

In response, the Food and Drug Administration earlier this week threatened to pull e-cigarettes from shelves if manufacturers do not control teen use. The agency is specifically ordering five brands — Juul, British American Tobacco‘s Vuse, Altria‘s MarkTen, Imperial Brands‘ Blu E-cigs and Japan Tobacco‘s Logic — to submit plans within 60 days detailing how they will prevent teens from using their products.

Azar said he “completely supports” FDA in its proposed crackdown Friday in an interview with CNBC’s “Squawk on the Street.” A father of teens himself, he said he sees the “pervasiveness” and “rapid spread” of teen e-cigarette use.

FDA Commissioner Scott Gottlieb told CNBC on Thursday the FDA will soon publicly release new data showing the proportion of high school teenagers using e-cigarettes has “reached nothing short of an epidemic.”

Tobacco stocks surged after the news, as investors speculated it was good news for cigarettes and a win for Big Tobacco.

“I wouldn’t want to speculate on the way the stock market reacts in the way that it does,” Azar said. “I think it’s also important to remember … combustible companies do have e-cigarette product lines, and they may be forecasting that as we move into a much more heightened regulatory framework, capabilities and capacities to deal with a heightened regulatory environment.”

Articles You May Like

The Best Pickleball Shoes, According to Pros, Players, and Reviews
Scynexis Issues a Voluntary Nationwide Recall of Brexafemme (ibrexafungerp tablets) Due to Potential for Cross Contamination with a Non-Antibacterial ßlactam Drug Substance
How well do Americans eat for the planet? New index reveals gaps and opportunities in sustainable diets
What Is HMPV? Here’s All About The Lesser-Known Respiratory Illness Spreading In Australia
FDA Accepts Submission to Add PH-ILD to Yutrepia™ Label

Leave a Reply

Your email address will not be published. Required fields are marked *